If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.
United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
The Commerce Department reports that more than 15 million jobs could be affected by self-driving cars, many major hedge funds have sold shares of Apple and Facebook, and more headlines.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes before the closing bell.
Verizon, Boeing, Merck, and Disney were Thursday's leading DJIA gainers.
The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week: Caterpillar, DuPont, McDonald's, 3M, Boeing, Coca Cola, Procter &…
Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) in a close second.…
A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the report's top picks: AbbVie, Eli Lilly, Merck, and Shire.
